# Comparison of Efficacy and Safety of Albumin Versus Fresh Frozen Plasma in Managing Diuretic Resistant Edema in Children With Idiopathic Nephrotic Syndrome.

> **NCT07685093** · NA · NOT_YET_RECRUITING · sponsor: **Qamar Shafiq** · enrollment: 56 (estimated)

## Conditions studied

- Idiopathic Nephrotic Syndrome (INS)

## Interventions

- **BIOLOGICAL:** Human Albumin 20%
- **BIOLOGICAL:** Fresh Frozen Plasma

## Key facts

- **NCT ID:** NCT07685093
- **Lead sponsor:** Qamar Shafiq
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-05
- **Primary completion:** 2026-10-17
- **Final completion:** 2026-10-17
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2026-07-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07685093

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07685093, "Comparison of Efficacy and Safety of Albumin Versus Fresh Frozen Plasma in Managing Diuretic Resistant Edema in Children With Idiopathic Nephrotic Syndrome.". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07685093. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*